Vaccines in Farm Animals

Dear Colleagues,

Many infectious diseases are originated from livestock. Most of these diseases are or may potentially be transmitted to humans either directly or through animal products. In addition, other infections not affecting human can still produce important economic losses in the agricultural/livestock sector. Although there have been some advancements in the development of treatments and farmers and veterinarians are more and more trained to perform more accurate tests to stop the spread of these diseases, the most efficient way of preventing these setbacks is by immunoprophylaxis. In this special issue we focus on the development, characterization, field trials and efficiency tests of vaccines aimed at stopping or preventing diseases affecting animals and humans, with an especial interest in those related to livestock.

To this end, we invite you to submit an original research or review to this Special Issue covering (but not limited to) the following topics:

a) Vaccines against protozoan parasites (e.g. Toxoplasma, Neospora, Eimeria, Theileria, Tritrichomonas…)

b) Vaccines against diseases affecting ruminants, with especial interest in those vertically transmitted or causing abortion (protozoans, viruses, bacteria…)

c) Vaccines against diseases transmitted to humans through animal products (meat, milk, eggs…)

d) Recombinant or inactivated vaccine trials in livestock (cattle, sheep, goat, poultry, pigs…)

e) Vaccines based on genetically modified organisms affecting animals and humans (knockout, exogenous expression of heterologous proteins/antigens)

We are looking forward to your interesting manuscript and do not hesitate to contact us should you require further information.

Dr. David Arranz-Solís
Dr. Yanina Paola Hecker
Dr. Valentin Pérez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.